Sana Biotechnology, Inc. (SANA)
SANA moved a median of -0.07% 30 minutes after news, and 0.00% by the close. How SANA actually reacts to news — the realized, point-in-time move the market made, measured across 782 labeled events over the last three years with zero look-ahead.
SANA’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 782 |
| 30-min | -0.07% | 46% | 782 |
| 60-min | +0.25% | 51% | 782 |
| to close | 0.00% | 48% | 779 |
| Middle 50% of SANA reactions | -1.99% to +1.65% |
|---|---|
| Median reaction (30-min) | -0.07% |
| Measured reactions | 782 |
Half of all Sana Biotechnology, Inc. news events land between -1.99% and +1.65% at 30 minutes.
Reaction stats as of 2026-08-31. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How SANA reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 16 | -0.40% | 44% | -2.37% |
| Coverage initiations | 17 | -1.50% | 47% | +1.79% |
| Rating reiterations | 31 | -0.92% | 29% | -0.60% |
Last 3 years, pulled 2026-08-31. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 3 further classes were observed with fewer than 10 measured events and are not published. See how SANA ranks against every other measured name →
That’s how SANA usually reacts — get an email when it moves on news →Email me when SANA moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to SANA's baseline. Nothing else.
Recent SANA events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Sana Biotechnology to Present at September 2026 Investor Conferences | Press release | GlobeNewswire | +3.90% | +1.04% | |
| Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | +0.64% | +0.64% | |
| Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes | Press release | GlobeNewswire | -1.99% | -3.45% | |
| Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026 | Press release | GlobeNewswire | -0.57% | +2.30% | |
| Form 8-K Sana Biotechnology, Inc. For: Jun 04 | SEC filing · Form 8-K | SEC EDGAR | -1.64% | -1.82% | |
| Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Press release | PR Newswire | -2.17% | -3.41% | |
| Sana Biotechnology to Present at June 2026 Investor Conferences | Press release | GlobeNewswire | -1.65% | +2.96% | |
| Form 8-K Sana Biotechnology, Inc. For: May 15 | SEC filing · Form 8-K | SEC EDGAR | +1.47% | -0.98% | |
| Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility | Press release | GlobeNewswire | -2.95% | +0.66% | |
| Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs | Press release | GlobeNewswire | -2.46% | -1.54% | |
| Form 10-Q Sana Biotechnology, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.85% | -7.39% | |
| Form 8-K Sana Biotechnology, Inc. For: May 11 | SEC filing · Form 8-K | SEC EDGAR | -0.85% | -7.39% | |
| Form S-8 Sana Biotechnology, Inc. | SEC filing · Form S-8 | SEC EDGAR | -0.85% | -7.39% | |
| Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates | Press release | GlobeNewswire | -0.85% | -7.39% | |
| Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference | Press release | GlobeNewswire | +0.15% | +4.30% | |
| Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting | Press release | GlobeNewswire | +1.84% | +2.76% | |
| Form 8-K Sana Biotechnology, Inc. For: Apr 22 | SEC filing · Form 8-K | SEC EDGAR | -0.29% | -3.80% | |
| Form ARS Sana Biotechnology, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.29% | -3.80% | |
| Form DEF 14A Sana Biotechnology, Inc. For: Jun 04 | SEC filing · Form DEF | SEC EDGAR | -0.29% | -3.80% | |
| Form DEFA14A Sana Biotechnology, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -0.29% | -3.80% | |
| Form 8-K Sana Biotechnology, Inc. For: Apr 10 | SEC filing · Form 8-K | SEC EDGAR | +0.38% | -12.78% | |
| Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451 | Press release | GlobeNewswire | +0.38% | -12.78% | |
| Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression | Press release | GlobeNewswire | +0.63% | +5.33% | |
| Form 10-K Sana Biotechnology, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -4.04% | -0.52% | |
| Form 8-K Sana Biotechnology, Inc. For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | -4.04% | -0.52% | |
| Form S-3ASR Sana Biotechnology, Inc. | SEC filing · Form S-3ASR | SEC EDGAR | -4.04% | -0.52% | |
| Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates | Press release | GlobeNewswire | -4.04% | -0.52% | |
| Sana Biotechnology to Present at March 2026 Investor Conferences | Press release | GlobeNewswire | +3.18% | +3.42% | |
| Form 8-K Sana Biotechnology, Inc. For: Feb 17 | SEC filing · Form 8-K | SEC EDGAR | +0.52% | +0.79% | |
| Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer | Press release | GlobeNewswire | +0.52% | +0.79% | |
| Form 8-K Sana Biotechnology, Inc. For: Jan 14 | SEC filing · Form 8-K | SEC EDGAR | +2.62% | -0.73% | |
| Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference | Press release | GlobeNewswire | +2.98% | -3.83% | |
| Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform | Press release | GlobeNewswire | -2.79% | -13.78% | |
| Sana Biotechnology to Present at December 2025 Investor Conferences | Press release | GlobeNewswire | +0.41% | -3.04% | |
| Form 10-Q Sana Biotechnology, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.04% | +4.60% | |
| Form 8-K Sana Biotechnology, Inc. For: Nov 06 | SEC filing · Form 8-K | SEC EDGAR | -0.04% | +4.60% | |
| Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates | Press release | GlobeNewswire | -0.04% | +4.60% | |
| Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit | Press release | GlobeNewswire | -0.95% | -3.09% | |
| Form 8-K Sana Biotechnology, Inc. For: Sep 04 | SEC filing · Form 8-K | SEC EDGAR | +0.17% | -0.34% | |
| Form 8-K Sana Biotechnology, Inc. For: Aug 28 | SEC filing · Form 8-K | SEC EDGAR | +1.33% | -5.65% | |
| Sana Biotechnology to Present at September 2025 Investor Conferences | Press release | GlobeNewswire | -0.15% | +4.01% | |
| Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares | Press release | GlobeNewswire | -2.02% | +4.05% | |
| Form 10-Q Sana Biotechnology, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +2.24% | — | |
| Form 8-K Sana Biotechnology, Inc. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +2.24% | — | |
| Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates | Press release | GlobeNewswire | +2.24% | — | |
| Form 8-K Sana Biotechnology, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -1.83% | -0.33% | |
| Form 8-K Sana Biotechnology, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -4.62% | -8.62% | |
| Sana Biotechnology Announces Pricing of Public Offering | Press release | GlobeNewswire | -4.62% | -8.62% | |
| Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Press release | GlobeNewswire | -4.62% | -8.62% | |
| Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes | Press release | GlobeNewswire | +1.51% | +6.28% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the SANA section they belong to.
Where else SANA is measured.
SANA earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Sana Biotechnology, Inc.'s median reaction calculated?
Every labeled SANA news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 782 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 46% of SANA's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-08-31.
Does SANA's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.